Your browser doesn't support javascript.
loading
Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial.
Procter, Marion; Suter, Thomas M; de Azambuja, Evandro; Dafni, Urania; van Dooren, Veerle; Muehlbauer, Susanne; Climent, Miguel Angel; Rechberger, Ernst; Liu, Walter Tsang-Wu; Toi, Mazakasu; Coombes, R Charles; Dodwell, David; Pagani, Olivia; Madrid, Jorge; Hall, Marcia; Chen, Shin-Cheh; Focan, Christian; Muschol, Michael; van Veldhuisen, Dirk J; Piccart-Gebhart, Martine J.
Affiliation
  • Procter M; Frontier Science Scotland, Kincraig, Kingussie, Imperial College London, London, UK.
J Clin Oncol ; 28(21): 3422-8, 2010 Jul 20.
Article in En | MEDLINE | ID: mdl-20530280
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Heart Failure / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Clinical_trials Limits: Female / Humans Language: En Journal: J Clin Oncol Year: 2010 Document type: Article Affiliation country: United kingdom Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Heart Failure / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Clinical_trials Limits: Female / Humans Language: En Journal: J Clin Oncol Year: 2010 Document type: Article Affiliation country: United kingdom Country of publication: United States